ScreenerHero

HYPRHyperfine Inc. Class A Common Stock

NAS · US · Healthcare · Medical Devices · hyperfinemri.com
0.9021USD+0.03%Mkt Cap: 95.67M $P/E: —

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lowe…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$203.22BUSDP/E 37.8
SYK
Stryker Corporation
$125.74BUSDP/E 34.0
MDT
Medtronic plc
$118.91BUSDP/E 24.9
BSX
Boston Scientific Corporation
$71.03BUSDP/E 19.8
SHL
Siemens Healthineers AG
$48.43BUSDP/E 19.9
EW
Edwards Lifesciences Corporation
$52.11BUSDP/E 53.9
DXCM
DexCom, Inc.
$34.85BUSDP/E 36.5
GEHC
GE HealthCare Technologies Inc. Common Stock
$34.04BUSDP/E 17.2
PHIA
Koninklijke Philips N.V.
$25.08BUSDP/E 20.7
PHG
Koninklijke Philips N.V.
$26.90BUSDP/E 20.7
STE
STERIS plc
$23.19BUSDP/E 29.1
ZBH
Zimmer Biomet Holdings, Inc.
$19.26BUSDP/E 24.5
PEN
Penumbra, Inc.
$12.75BUSDP/E 79.7
SNN
Smith & Nephew plc
$12.40BUSDP/E 20.1
GMED
Globus Medical, Inc.
$11.29BUSDP/E 21.5
GKOS
Glaukos Corporation
$10.95BUSD
SN
Smith & Nephew plc
$9.84BUSDP/E 20.0
PODD
Insulet Corporation
$10.28BUSDP/E 27.5
BIO
Bio-Rad Laboratories, Inc.
$10.22BUSDP/E 46.5
DEMANT
Demant A/S
$8.82BUSDP/E 25.0
HeadlineSourceTime
Older
Hyperfine (HYPR) Q2 2026 Earnings Call Transcript

Portable MRI revenue surged 45% as system sales jumped 50% year over year.

Motley Fool
Hyperfine, Inc. Q2 2026 Earnings Call Summary

Moby summary of Hyperfine, Inc.'s Q2 2026 earnings call

Moby
Hyperfine Inc (HYPR) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% on Strong System ...

Gross margins remain above 50% for the fourth consecutive quarter, while the company reiterates its full-year revenue guidance of $20-22 million.

GuruFocus.com
Hyperfine Q2 Earnings Call Highlights

Hyperfine (NASDAQ:HYPR) reported second-quarter revenue of $3.9 million, up approximately 45% from a year earlier, as the portable MRI company cited growth across hospital, neurology office and international markets. The company sold 12 systems during the quarter, compared with eight in the prior-y

MarketBeat
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates

Hyperfine (HYPR) delivered earnings and revenue surprises of 0.00% and -7.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates

RxSight (RXST) delivered earnings and revenue surprises of +47.62% and +2.56%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +16.13% and +3.64%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Hyperfine launches next-generation Swoop MRI system in Europe
Hospital Management
Hyperfine shares rise after expected Russell index addition (HYPR)
InvestorsHub
Hyperfine, Inc. Q1 2026 Earnings Call Summary

Moby summary of Hyperfine, Inc.'s Q1 2026 earnings call

Moby